Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MELADERM-trial: Melatonin cream against acute radiation dermatitis in early breast cancer
2018-001705-91Phase 2Completed
- Sponsor
- Center for Perioperative Optimization, Department of Surgery, Herlev Hospital
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in radiodermatitis and breast cancer comparing Melatonin cream with Placebo cream (2 arms). Primary endpoint: Acute radiation morbidity of the skin (RTOG). Started Jul 2018; status: completed.
02
Drugs
melatonin
03
Conditions
radiodermatitisbreast cancer
Beyond the preview
Go deeper on 2018-001705-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001705-91.